Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions
Drug repurposing or repositioning has been well-known to refer to the therapeutic applications of a drug for another indication other than it was originally approved for. Repurposing non-oncology small-molecule drugs has been increasingly becoming an attractive approach to improve cancer therapy, wi...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | Leilei Fu (Συγγραφέας), Wenke Jin (Συγγραφέας), Jiahui Zhang (Συγγραφέας), Lingjuan Zhu (Συγγραφέας), Jia Lu (Συγγραφέας), Yongqi Zhen (Συγγραφέας), Lan Zhang (Συγγραφέας), Liang Ouyang (Συγγραφέας), Bo Liu (Συγγραφέας), Haiyang Yu (Συγγραφέας) |
---|---|
Μορφή: | Βιβλίο |
Έκδοση: |
Elsevier,
2022-02-01T00:00:00Z.
|
Θέματα: | |
Διαθέσιμο Online: | Connect to this object online. |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
από: Xin Jin, κ.ά.
Έκδοση: (2024) -
Inhibiting Cytoprotective Autophagy in Cancer Therapy: An Update on Pharmacological Small-Molecule Compounds
από: Lijuan Zhang, κ.ά.
Έκδοση: (2022) -
Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules
από: Yan-Chuang Han, κ.ά.
Έκδοση: (2016) -
Screening Repurposed Antiviral Small Molecules as Antimycobacterial Compounds by a Lux-Based phoP Promoter-Reporter Platform
από: Li Zhu, κ.ά.
Έκδοση: (2022) -
"Hard" Drug Repurposing for Precision Oncology: The Missing Link?
από: Pan Pantziarka, κ.ά.
Έκδοση: (2018)